Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
A solid budget helps young professionals manage irregular income and set aside funds for future goals.
19,978 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Wall Street chatter about a SpaceX and Tesla merger has sparked a wave of questions. This article unpacks what the ph...
A bold growth push could redefine Energy Transfer's cash flow and risk. This year’s capex plan signals a major shift ...
BWET surged about 19% in early trading as tanker freight costs climb on supply disruptions and rerouted crude shipmen...
Investors watched the latest inflation data closely as Warsh took the helm. This article explains why softer inflatio...
Both Tesla and Rivian have slipped about 12% this year. This article cuts through the market noise to evaluate fundam...
Thinking about should tesla stock before July 22 earnings? This guide breaks down potential catalysts, risk factors, ...
ARKK and ARKG are back in the biotech spotlight as Cathie Wood makes new bets after a setback in a key antisense stoc...
Palantir trades at lofty multiples, but its growth engine is real. This piece weighs the high valuation against the b...
As UCB prepares to reveal Q2 results, investors should focus on revenue mix, pipeline progress, and margin resilience...
ADP boosted its quarterly payout by 10% to $1.70, marking its 50th consecutive year of dividend growth. This mileston...
When markets plunge, the question isn’t just about losses. Could buying Ethereum during a crypto crash turn into mean...